Glyn Edwards talks about cancer drug development at Antisoma. Interview by Ulrike Knies-Bamforth and Dan Huke

We're an exclusively oncology development-focused company; we've put together a portfolio of projects, which are rather different from each other, which is our way of diversifying the systemic risk out of the portfolio.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Drug discovery today 2005-11, Vol.10 (22), p.1491
1. Verfasser:	Edwards, Glyn
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Agents - chemistry Antineoplastic Agents - therapeutic use Biomedical Research Clinical Trials as Topic Drug Industry - organization & administration Neoplasms - drug therapy Organizational Objectives
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	We're an exclusively oncology development-focused company; we've put together a portfolio of projects, which are rather different from each other, which is our way of diversifying the systemic risk out of the portfolio.
ISSN:	1359-6446